Maja Henjakovic

Dr. Maja Henjakovic

Department of Medicine, Danube Private University, Krems, Austria
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2008 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
Maja HenjakovicMaja Henjakovic
Maja Henjakovic
KSK. Sewald
K. Sewald
SSS. Switalla
S. Switalla
DKD. Kaiser
D. Kaiser
MMM. Müller
M. Müller
ABA. Braun
A. Braun

4 September 2008 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
Maja HenjakovicMaja Henjakovic
Maja Henjakovic
CMC. Martin
C. Martin
HHH. G. Hoymann
H. G. Hoymann
KSK. Sewald
K. Sewald
ARA. R. Ressmeyer
A. R. Ressmeyer
ABA. Braun
A. Braun
A wide range of industrial chemicals can induce respiratory allergic reactions. Hence, there is an urgent need for methods identifying and characterizing the biological action of chemicals in the lung. Here, we present an easy, reliable alternative method to measure lung function changes ex vivo after exposure to chemical allergens and compare this to invasive in vivo measurements after sensitization with the industrial chemicals trimellitic anhydride (TMA) and 2,4-dinitrochlorobenzene (DNCB). Female BALB/c mice were sensitized epicutaneously with the respiratory allergen TMA and the contact sensitizer DNCB. The early allergic response to TMA and DNCB was registered in vivo and ex vivo on day 21 after inhalational challenge with dry standardized aerosols or after exposure of precision-cut lung slices (PCLS) to dissolved allergen. Airway hyperresponsiveness (AHR) to increasing doses of methacholine (MCh) was measured on the next day in vivo and ex vivo. Bronchoalveolar lavage (BAL) was performed for immunological characterization of local inflammation. TMA-sensitized mice showed AHR to MCh in vivo (ED50: 0.06 μg MCh vs. 0.21 μg MCh in controls) and in PCLS (EC50: 0.24 μM MCh vs. 0.4 μM MCh). TMA-treated animals showed increased numbers of eosinophils (12.8·104 vs. 0.7·104) and elevated eotaxin-2 concentrations (994 pg/ml vs. 167 pg/ml) in BAL fluid 24 h after allergen challenge. In contrast, none of these parameters differed after sensitization with DNCB. The present study suggests that the effects of low molecular weight allergens, like TMA and DNCB, on ex vivo lung functions tested in PCLS reflect the in vivo situation.

11 July 2006 in Human Mutation
Verified
Journal Article
Open access
PDF file
VSVeronika Schulz
Veronika Schulz
DHDoris Hendig
Doris Hendig
Maja HenjakovicMaja Henjakovic
Maja Henjakovic
CSChristiane Szliska
Christiane Szliska
KKKnut Kleesiek
Knut Kleesiek
CGChristian Götting
Christian Götting
Pseudoxanthoma elasticum (PXE) is a genetic disorder characterized by calcification of elastic fibers in dermal, ocular, and cardiovascular tissues. Recently, ABCC6 mutations were identified as causing PXE. In this follow-up study we report the investigation of 61 German PXE patients from 53 families, hitherto the largest cohort of German PXE patients screened for the complete ABCC6 gene. In addition, we characterized the proximal ABCC6 promoter of PXE patients according to mutation. In this study we identified 32 disease-causing ABCC6 variants, which had been described previously by us and others, and 10 novel mutations (eight missense mutations and two splice site alterations). The mutation detection rate among index patients was 87.7%. Frequent alterations were the PXE-mutations p.R1141X, Ex23,_Ex29del, and c.2787+1G>T. In the ABCC6 promoter we found the polymorphisms c.–127C>T, c.–132C>T, and c.–219A>C. The difference in the c.–219A>C frequencies between PXE patients and controls were determined as statistically significant. Interestingly, c.–219A>C is located in a transcriptional activator sequence of the ABCC6 promoter and occurred in a binding site for a transcriptional repressor, predominantly found in genes that participate in lipid metabolism. Obtaining these genetic data signifies our contribution to elucidating the pathogenetics of PXE.

1 April 2012 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
PDF file
SGShivangi Gupta
Shivangi Gupta
GWGerald Wulf
Gerald Wulf
Maja HenjakovicMaja Henjakovic
Maja Henjakovic
HKHermann Koepsell
Hermann Koepsell
GBGerhard Burckhardt
Gerhard Burckhardt
YHYohannes Hagos
Yohannes Hagos
Antineoplastic agents directed at nuclear and cytoplasmic targets in tumor cells represent the current mainstay of treatment for patients with disseminated malignant diseases. Cellular uptake of antineoplastics is a prerequisite for their efficacy. Five of six lymphoma cell lines as well as primary samples from chronic lymphocytic leukemia patients demonstrated significant expression of SLC22A1 mRNA coding for organic cation transporter 1 (OCT1). Functionally, the antineoplastic agents irinotecan, mitoxantrone, and paclitaxel inhibited the uptake of the organic cation [3H]1-methyl-4-pyridinium iodide into OCT1-transfected Chinese hamster ovary model cells, with Ki values of 1.7, 85, and 50 μM, respectively. Correspondingly, OCT1-positive cell lines and transfectants exhibited significantly higher susceptibilities to the cytotoxic effects of irinotecan and paclitaxel compared with those of OCT1-negative controls. We hypothesize that OCT1 can contribute to the susceptibility of cancer cells to selected antineoplastic drugs. In the future, an expression analysis of the transporters and the application of transporter-specific antineoplastic agents could help to tailor cancer therapy.

1 November 2011 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
MKMarcel Kaufhold
Marcel Kaufhold
KSKatharina Schulz
Katharina Schulz
DBDavorka Breljak
Davorka Breljak
SGShivangi Gupta
Shivangi Gupta
Maja HenjakovicMaja Henjakovic
Maja Henjakovic
GBGerhard Burckhardt
Gerhard Burckhardt
Organic anions are taken up from the blood into proximal tubule cells by organic anion transporters 1 and 3 (OAT1 and OAT3) in exchange for dicarboxylates. The released dicarboxylates are recycled by the sodium dicarboxylate cotransporter 3 (NaDC3). In this study, we tested the substrate specificities of human NaDC3, OAT1, and OAT3 to identify those dicarboxylates for which the three cooperating transporters have common high affinities. All transporters were stably expressed in HEK293 cells, and extracellularly added dicarboxylates were used as inhibitors of [14C]succinate (NaDC3), p-[3H]aminohippurate (OAT1), or [3H]estrone-3-sulfate (OAT3) uptake. Human NaDC3 was stably expressed as proven by immunochemical methods and by sodium-dependent uptake of succinate ( K0.5for sodium activation, 44.6 mM; Hill coefficient, 2.1; Kmfor succinate, 18 μM). NaDC3 was best inhibited by succinate (IC5025.5 μM) and less by α-ketoglutarate (IC5069.2 μM) and fumarate (IC5095.2 μM). Dicarboxylates with longer carbon backbones (adipate, pimelate, suberate) had low or no affinity for NaDC3. OAT1 exhibited the highest affinity for glutarate, α-ketoglutarate, and adipate (IC50between 3.3 and 6.2 μM), followed by pimelate (18.6 μM) and suberate (19.3 μM). The affinity of OAT1 to succinate and fumarate was low. OAT3 showed the same dicarboxylate selectivity with ∼13-fold higher IC50values compared with OAT1. The data 1) reveal α-ketoglutarate as a common high-affinity substrate of NaDC3, OAT1, and OAT3 and 2) suggest potentially similar molecular structures of the binding sites in OAT1 and OAT3 for dicarboxylates.

15 November 2015 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
Maja HenjakovicMaja Henjakovic
Maja Henjakovic
YHYohannes Hagos
Yohannes Hagos
WKWolfgang Krick
Wolfgang Krick
GBGerhard Burckhardt
Gerhard Burckhardt
BBBirgitta C. Burckhardt
Birgitta C. Burckhardt
Phylogentically, organic anion transporter (OAT)1 and OAT3 are closely related, whereas OAT2 is more distant. Experiments with human embryonic kidney-293 cells stably transfected with human OAT1, OAT2, or OAT3 were performed to compare selected transport properties. Common to OAT1, OAT2, and OAT3 is their ability to transport cGMP. OAT2 interacted with prostaglandins, and cGMP uptake was inhibited by PGE2and PGF2αwith IC50values of 40.8 and 12.7 μM, respectively. OAT1 (IC50: 23.7 μM), OAT2 (IC50: 9.5 μM), and OAT3 (IC50: 1.6 μM) were potently inhibited by MK571, an established multidrug resistance protein inhibitor. OAT2-mediated cGMP uptake was not inhibited by short-chain monocarboxylates and, as opposed to OAT1 and OAT3, not by dicarboxylates. Consequently, OAT2 showed no cGMP/glutarate exchange. OAT1 and OAT3 exhibited a pH and a Cl−dependence with higher substrate uptake at acidic pH and lower substrate uptake in the absence of Cl−, respectively. Such pH and Cl−dependencies were not observed with OAT2. Depolarization of membrane potential by high K+concentrations in the presence of the K+ionophore valinomycin left cGMP uptake unaffected. In addition to cGMP, OAT2 transported urate and glutamate, but cGMP/glutamate exchange could not be demonstrated. These experiments suggest that OAT2-mediated cGMP uptake does not occur via exchange with monocarboxylates, dicarboxylates, and hydroxyl ions. The counter anion for electroneutral cGMP uptake remains to be identified.